Abstract CT264: Mutant KRAS peptide vaccine combined with ipilimumab/nivolumab in advanced mismatch repair proficient/microsatellite stable (MMRp/MSS) colorectal cancer: Preliminary analysis from a phase I studyHejia Wang, Neeha Zaidi, Saurav D. Haldar et al.|Cancer Research|2025Cited by 3